Related Experiment Video
Updated: Mar 12, 2026
17:50
Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
Published on: July 4, 2007
13.0K
[Transparency in public health decision-making].
Anna García-Altés1, Josep M Argimon2
1Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, España; CIBER de Epidemiología y Salud Pública (CIBERESP), España; Institut d'Investigació Biomèdica (IIB Sant Pau), Barcelona, España.
Gaceta Sanitaria
|November 14, 2016
Summary
The Catalan healthcare system
Area of Science:
- Public Health
- Healthcare Management
- Health Policy
Background:
- Improving governmental healthcare decision-making is crucial for population health.
- Transparency and performance feedback enhance healthcare quality.
- Benchmarking healthcare centers drives better outcomes.
Purpose of the Study:
- To introduce the "Results Centre" initiative in the Catalan healthcare system.
- To promote transparency and accountability in healthcare.
- To facilitate shared decision-making for improved healthcare quality.
Main Methods:
- Establishing a "Results Centre" to measure and disseminate healthcare performance.
- Comparing results across different healthcare centers.
- Providing transparent feedback to professionals and the public.
Main Results:
- The "Results Centre" facilitates a shared decision-making process.
- The initiative enhances the quality of healthcare in Catalonia.
- It represents a pioneering step towards transparency in Spanish healthcare.
Conclusions:
- The "Results Centre" model improves healthcare quality through transparency and accountability.
- This initiative aligns Catalonia with leading countries in healthcare transparency.
- Disseminating results fosters continuous improvement in public healthcare.
Related Concept Videos
01:26Principles of Disease Surveillance
745
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
745
01:18Steps in Outbreak Investigation
680
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
680
01:22Healthcare Associated Infections II: Preventive Measures
4.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
632
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
632
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
59
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59
01:25Ethical Standards I
1.7K
The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
1.7K